Exelixis
EXEL
#1593
Rank
S$17.82 B
Marketcap
S$70.92
Share price
-2.03%
Change (1 day)
24.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company